Paul Lerner
New Hyde Park, NYNPI 1861411456
Payments from drug & device makers
Across 291 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$862
- Teva Pharmaceuticals USA, Inc.$638
- Biogen$403
- Amneal Pharmaceuticals LLC$335
- Biohaven Pharmaceutical Holding Company Ltd.$312
- Novartis$301
- plus $3K from 28 others
What the payments were for
- Speaking & faculty fees$401%
- Food & beverage$5,58098%
- Education$771%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $862 |
| Teva Pharmaceuticals USA, Inc. | 36 | $638 |
| Biogen | 23 | $403 |
| Amneal Pharmaceuticals LLC | 12 | $335 |
| Biohaven Pharmaceutical Holding Company Ltd. | 21 | $312 |
| Novartis | 20 | $301 |
| Corium, LLC | 17 | $285 |
| Boston Scientific | 3 | $267 |
| Biohaven Pharmaceuticals, Inc. | 9 | $243 |
| Lilly USA, LLC | 16 | $229 |
| Amgen | 9 | $221 |
| AstraZeneca(2 entities) | 5 | $211 |
| Neurocrine Biosciences, Inc. | 10 | $194 |
| Sanofi | 8 | $160 |
| Pfizer | 8 | $140 |
| Vertical Pharmaceuticals, LLC | 5 | $108 |
| Lundbeck LLC | 5 | $103 |
| Alkermes, Inc. | 4 | $89 |
| Eisai Inc. | 4 | $87 |
| Johnson & Johnson | 4 | $79 |
| Assertio Therapeutics, Inc. | 5 | $79 |
| SK Life Science, Inc. | 3 | $68 |
| E.r. Squibb & Sons, L.L.C. | 1 | $41 |
| Acorda Therapeutics, Inc | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Currax Pharmaceuticals LLC | 1 | $23 |
| Catalyst Pharmaceuticals, Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Neurelis, Inc. | 1 | $21 |
| Adamas Pharmaceuticals, Inc. | 1 | $21 |
| Medtronic | 1 | $19 |
| UCB, Inc. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL PAIN MANAGEMENT$209
- FASENRA$124
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.